Login
$TRDA
$4.41 -$0.34 (7.16%) Close

Insider Transactions

What Entrada Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 17
Sells 33 44
Total trades 37 78

Shares traded

3 months 12 months
Acquired 0 522,511
Disposed 1,457,972 2,020,201
Net activity −1,457,972 −1,497,690

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Mpm Bioventures 2018, L.p. 10% owner Sep 09 Open-market sale · S −28,837 $7.13 −$206K 3,885,115
Mpm BioVentures 2014, L.p. 10% owner Sep 09 Open-market sale · S −28,837 $7.13 −$206K 3,885,115
Mpm Bioventures 2018, L.p. 10% owner Sep 08 Open-market sale · S −192,500 $7.41 −$1.43M 3,913,952
Mpm BioVentures 2014, L.p. 10% owner Sep 08 Open-market sale · S −192,500 $7.41 −$1.43M 3,913,952
Mpm Bioventures 2018, L.p. 10% owner Sep 04 Open-market sale · S −38,500 $7.11 −$274K 4,106,452
Mpm BioVentures 2014, L.p. 10% owner Sep 04 Open-market sale · S −38,500 $7.11 −$274K 4,106,452
Mpm BioVentures 2014, L.p. 10% owner Sep 03 Open-market sale · S −32,263 $7.17 −$231K 4,144,952
Mpm Bioventures 2018, L.p. 10% owner Sep 03 Open-market sale · S −32,263 $7.17 −$231K 4,144,952
Wentworth Kory James Chief Financial Officer Sep 02 Withheld — tax / exercise cost · F −1,733 $7.14 −$12.4K 117,277
Sethuraman Natarajan President, Research & Develop. Sep 02 Withheld — tax / exercise cost · F −2,079 $7.14 −$14.9K 214,238
Dowden Nathan J President & COO Sep 02 Withheld — tax / exercise cost · F −2,528 $7.14 −$18.1K 196,060
Mpm BioVentures 2014, L.p. 10% owner Sep 02 Open-market sale · S −25,131 $7.19 −$181K 4,177,215
Doshi Dipal CEO Sep 02 Withheld — tax / exercise cost · F −8,724 $7.14 −$62.3K 517,290
Mpm Bioventures 2018, L.p. 10% owner Sep 02 Open-market sale · S −25,131 $7.19 −$181K 4,177,215
Mpm BioVentures 2014, L.p. 10% owner Sep 01 Open-market sale · S −29,088 $7.06 −$205K 4,202,346
Mpm Bioventures 2018, L.p. 10% owner Sep 01 Open-market sale · S −29,088 $7.06 −$205K 4,202,346
Mpm Bioventures 2018, L.p. 10% owner Aug 31 Open-market sale · S −44,259 $6.99 −$309K 4,231,434
Mpm BioVentures 2014, L.p. 10% owner Aug 31 Open-market sale · S −44,259 $6.99 −$309K 4,231,434
Mpm Bioventures 2018, L.p. 10% owner Aug 28 Open-market sale · S −3,733 $7.01 −$26.2K 4,275,693
Mpm BioVentures 2014, L.p. 10% owner Aug 28 Open-market sale · S −3,733 $7.01 −$26.2K 4,275,693

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support